Abbott, Biotest To Team Up On Treatment For Arthritis, Psoriasis - Wall Street Journal

Abbott, Biotest To Team Up On attention For Arthritis, Psoriasis divider Street Journal XE) to develop and commercialize the Germany-based company's treatment for rheumatoid arthritis and disease of the skin . Under the agreement, Abbott will pay AN upfront fee of $85 million to Biotest, which specializes in haematology and immunology products. ... Abbott, Biotest seal deal concluded arthritis drug Reuters Abbott inks $470M pact for Biotest's Ph2 RA antibody program FierceBiotech Abbott and Biotest Announce Global statement to Develop and tap ... PR Newswire (press release) all 33 tidings articles » Link To Article